These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 34551832

  • 1. Favourable outcome for hydrops or cardiac failure associated with fetal tachyarrhythmia: a 20-year review.
    Tunca Sahin G, Beattie RB, Uzun O.
    Cardiol Young; 2022 Jul; 32(7):1077-1084. PubMed ID: 34551832
    [Abstract] [Full Text] [Related]

  • 2. Treatment, not delivery, of the late preterm and term fetus with supraventricular arrhythmia.
    Holmes S, Hornberger LK, Jaeggi E, Howley L, Moon-Grady AJ, Uzun O, Kaizer A, Gilicze O, Cuneo BF.
    Ultrasound Obstet Gynecol; 2023 Oct; 62(4):552-557. PubMed ID: 37128167
    [Abstract] [Full Text] [Related]

  • 3. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment.
    Uzun O, Babaoglu K, Sinha A, Massias S, Beattie B.
    Cardiol Young; 2012 Aug; 22(4):372-80. PubMed ID: 22008551
    [Abstract] [Full Text] [Related]

  • 4. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia.
    Frohn-Mulder IM, Stewart PA, Witsenburg M, Den Hollander NS, Wladimiroff JW, Hess J.
    Prenat Diagn; 1995 Dec; 15(13):1297-302. PubMed ID: 8710768
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases].
    Jouannic JM, Delahaye S, Le Bidois J, Fermont L, Villain E, Dommergues M, Dumez Y.
    J Gynecol Obstet Biol Reprod (Paris); 2003 Jun; 32(4):338-44. PubMed ID: 12843882
    [Abstract] [Full Text] [Related]

  • 7. Prenatal diagnosis and management of fetal supraventricular tachyarrhythmia and postnatal outcomes.
    Demirci O, Tosun Ö, Bolat G.
    J Gynecol Obstet Hum Reprod; 2022 Mar; 51(3):102323. PubMed ID: 35063720
    [Abstract] [Full Text] [Related]

  • 8. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy.
    Parilla BV, Strasburger JF, Socol ML.
    Am J Perinatol; 1996 Nov; 13(8):483-6. PubMed ID: 8989479
    [Abstract] [Full Text] [Related]

  • 9. Refractory supraventricular fetal tachycardia as a cause of non-immune hydrops: management conundrum.
    Agarwal A, Saha SC, Kaur A, Naganur S.
    BMJ Case Rep; 2023 Dec 28; 16(12):. PubMed ID: 38154874
    [Abstract] [Full Text] [Related]

  • 10. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia.
    Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U.
    Heart; 2003 Aug 28; 89(8):913-7. PubMed ID: 12860871
    [Abstract] [Full Text] [Related]

  • 11. Complete resolution of arrhythmia-induced hydrops fetalis in utero.
    Narayanan M, Dhuka S, Alapati S, Kauffman RP.
    BMJ Case Rep; 2020 Oct 10; 13(10):. PubMed ID: 33040036
    [Abstract] [Full Text] [Related]

  • 12. Sotalol as an effective adjunct therapy in the management of supraventricular tachycardia induced fetal hydrops fetalis.
    Refaat M, El Dick J, Sabra M, Bitar F, Tayeh C, Abutaqa M, Arabi M.
    J Neonatal Perinatal Med; 2020 Oct 10; 13(2):267-273. PubMed ID: 31707376
    [Abstract] [Full Text] [Related]

  • 13. Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.
    Miyoshi T, Maeno Y, Hamasaki T, Inamura N, Yasukochi S, Kawataki M, Horigome H, Yoda H, Taketazu M, Nii M, Hagiwara A, Kato H, Shimizu W, Shiraishi I, Sakaguchi H, Ueda K, Katsuragi S, Yamamoto H, Sago H, Ikeda T, Japan Fetal Arrhythmia Group.
    J Am Coll Cardiol; 2019 Aug 20; 74(7):874-885. PubMed ID: 31416531
    [Abstract] [Full Text] [Related]

  • 14. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
    van der Heijden LB, Oudijk MA, Manten GT, ter Heide H, Pistorius L, Freund MW.
    Ultrasound Obstet Gynecol; 2013 Sep 20; 42(3):285-93. PubMed ID: 23303470
    [Abstract] [Full Text] [Related]

  • 15. [Diagnosis and treatment of haemodynamically significant fetal tachycardia--in 33 cases].
    Pete B, Hajdú J, Papp Z.
    Orv Hetil; 2004 Dec 26; 145(52):2611-7. PubMed ID: 15724696
    [Abstract] [Full Text] [Related]

  • 16. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
    Jaeggi ET, Carvalho JS, De Groot E, Api O, Clur SA, Rammeloo L, McCrindle BW, Ryan G, Manlhiot C, Blom NA.
    Circulation; 2011 Oct 18; 124(16):1747-54. PubMed ID: 21931080
    [Abstract] [Full Text] [Related]

  • 17. [European protocol for the management of fetal supraventricular tachycardia. European Association of Pediatric Cardiology].
    Azancot-Benisty A, Areias JC, Oberhänsli I, Schmidt KG, Tulzer G, Viart P.
    Arch Mal Coeur Vaiss; 1997 May 18; 90(5):735-43. PubMed ID: 9295960
    [No Abstract] [Full Text] [Related]

  • 18. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia.
    Krapp M, Baschat AA, Gembruch U, Geipel A, Germer U.
    Ultrasound Obstet Gynecol; 2002 Feb 18; 19(2):158-64. PubMed ID: 11876808
    [Abstract] [Full Text] [Related]

  • 19. Flecainide as first-line treatment for fetal supraventricular tachycardia.
    Ekiz A, Kaya B, Bornaun H, Acar DK, Avci ME, Bestel A, Yildirim G.
    J Matern Fetal Neonatal Med; 2018 Feb 18; 31(4):407-412. PubMed ID: 28114840
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias.
    Shah A, Moon-Grady A, Bhogal N, Collins KK, Tacy T, Brook M, Hornberger LK.
    Am J Cardiol; 2012 Jun 01; 109(11):1614-8. PubMed ID: 22444730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.